Key Considerations For Cryogenic Preservation And T Cell Viability
Source: Cytiva

Discerning fact from fiction when freezing T cells for cell therapies.
Cryopreservation provides critical protection for cell therapies by minimizing genetic changes. But cooling too slowly or quickly risks diminishing cell viability upon thaw. On 11 March 2020, Cytiva’s Peter Kilbride (senior research scientist) and Julie Meneghel (cryobiologist) discussed the importance of controlled-rate cryopreservation. Illustrating how mammalian cells change when frozen, they offered concrete cryopreservation strategies and identified temperatures at which it is safe to stop controlled cooling and transfer drug product to cryogenic storage.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more